Estados Unidos · Bolsa y Finanzas · The Motley Fool

Why Viking Therapeutics needs the cash

Publicado por The Motley Fool · Estados Unidos hace 9 h

Viking Therapeutics raised $575 million to fund major obesity drug trials, develop its pipeline, and support commercial development of any approvals for VK2735.

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

Why Viking Therapeutics needs the cash

También te puede interesar

Meta says it shut down No Kings Instagram account because it thought bots had been unleashed

Anthropic commits 5% of its stock to a new ‘public benefit’ fund and may give large donations to traditional nonprofits or to specific populations

SEC tokenized stock framework faces issuer pushback as Broadcom, Verizon object to OKX-ICE listing

10 things first-time cruisers wish they knew before boarding

India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance

Record Shipping Costs Force Oil Producers to Slash Prices

Why Viking Therapeutics needs the cash

Compartir

También te puede interesar

Meta says it shut down No Kings Instagram account because it thought bots had been unleashed

Anthropic commits 5% of its stock to a new ‘public benefit’ fund and may give large donations to traditional nonprofits or to specific populations

SEC tokenized stock framework faces issuer pushback as Broadcom, Verizon object to OKX-ICE listing

10 things first-time cruisers wish they knew before boarding

India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance

Record Shipping Costs Force Oil Producers to Slash Prices